Zevra Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Zevra Therapeutics, Inc. (ZVRA) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of 5.46 million shares as of 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber · last filed 2026-03-09
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 5.46M shares.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 5.95M shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 8.02M shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 2.46M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number as first filed |
|---|---|---|
| 2025-12-31 | 5.46M shares 10-K · filed 2026-03-09 | |
| 2024-12-31 | 5.95M shares 10-K · filed 2025-03-12 | |
| 2023-12-31 | 8.02M shares 10-K · filed 2024-04-01 | |
| 2022-12-31 | 2.46M shares 10-K · filed 2024-04-01 | |
| 2021-12-31 | 1.27M shares 10-K · filed 2023-03-07 | |
| 2020-12-31 | 355.79K shares 10-K · filed 2022-03-31 | |
| 2019-12-31 | 324.47K shares 10-K · filed 2021-03-12 | 5.19M shares 10-K · filed 2020-02-28 |
| 2018-12-31 | 3.70M shares 10-K · filed 2020-02-28 | |
| 2017-12-31 | 2.85M shares 10-K · filed 2019-03-01 | |
| 2016-12-31 | 1.99M shares 10-K · filed 2018-03-30 | |
| 2015-12-31 | 1.40M shares 10-K · filed 2017-03-10 | |
| 2015-01-01 | 395.19K shares 10-K · filed 2016-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |